Article Commentary: Peritoneal Defensins — Key Contributors to the Innate Immunity of the Peritoneal Cavity?

Abstract

Get full access to this article

View all access options for this article.

References

Jenssen

, Hamill

, Hancock

R.E.W.

Peptide antimicrobial agents.

Clin Microbiol Rev 2006; 19: 491–511.

Kapetanovic

, Cavaillon

J.M.

Early events in innate immunity in the recognition of microbial pathogens.

Expert Opin Biol Ther 2007; 7: 907–18.

Batoni

, Maisetta

, Esin

, Campa

Human beta-defensin-3: a promising antimicrobial peptide.

Mini Rev Med Chem 2006; 6: 1063–73.

Grupp

, Kimmel

, Fritz

, Voggenreiter

, Stöltzing

, Kuhlmann

The expression patterns of peritoneal defensins.

Perit Dial Int 2007; 27: 654–62.

Zarrinkalam

K.H.

, Leavesley

D.I.

, Stanley

J.M.

, Atkins

G.J.

, Faull

R.J.

Expression of defensin antimicrobial peptides in the peritoneal cavity of patients on peritoneal dialysis.

Perit Dial Int 2001; 21: 501–8.

Faull

R.J.

Peritoneal defenses against infection–winning the battle but losing the war?

Semin Dial 2000; 13: 47–53.

Mortier

, Lameire

N.H.

, De Vriese

A.S.

The effects of peritoneal dialysis solutions on peritoneal host defense.

Perit Dial Int 2004; 24: 123–38.